BioLineRx Historical Valuation

BLRX Stock  USD 3.42  0.16  4.47%   
Some fundamental drivers such as market cap or BioLineRx enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze BioLineRx valuation indicators such as Working Capital of 0.0 or Enterprise Value of 105.4 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of BioLineRx's future value.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLineRx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy BioLineRx Stock please use our How to Invest in BioLineRx guide.

About BioLineRx Valuation Data Analysis

Valuation is the financial process of determining what BioLineRx is worth. BioLineRx valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. BioLineRx valuation ratios help investors to determine whether BioLineRx Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioLineRx with respect to the benefits of owning BioLineRx security.

BioLineRx Valuation Data Chart

Enterprise Value is likely to rise to about 105.4 M in 2025, whereas Market Cap is likely to drop slightly above 68.4 M in 2025.

Enterprise Value

Enterprise Value (or EV) is usually referred to as BioLineRx theoretical takeover price. In the event of an acquisition, an acquirer would have to take on BioLineRx debt, but would also pocket its cash. Enterprise Value is more accurate representation of BioLineRx value than its market capitalization because it takes into account all of BioLineRx existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioLineRx Stock Analysis

When running BioLineRx's price analysis, check to measure BioLineRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLineRx is operating at the current time. Most of BioLineRx's value examination focuses on studying past and present price action to predict the probability of BioLineRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLineRx's price. Additionally, you may evaluate how the addition of BioLineRx to your portfolios can decrease your overall portfolio volatility.